published meta-analysis   sensitivity analysis   studies

anticoagulant, curative dose in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsGonzalez-Porras, 2020 0.40 [0.26; 0.62] 0.40[0.26; 0.62]Gonzalez-Porras, 202010%NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-06-01 06:51 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 830 - roots T: 290